These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26879069)

  • 1. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
    Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
    Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
    Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
    J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound--the TOGETHAR trial.
    Kodama K; Komatsu S; Ueda Y; Takayama T; Yajima J; Nanto S; Matsuoka H; Saito S; Hirayama A
    Circ J; 2010 Sep; 74(9):1922-8. PubMed ID: 20625215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome.
    Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y
    Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin.
    Otake H; Sugizaki Y; Toba T; Nagano Y; Tsukiyama Y; Yanaka KI; Yamamoto H; Nagasawa A; Onishi H; Takeshige R; Nakano S; Matsuoka Y; Tanimura K; Kawamori H; Shinke T; Hirata KI
    J Cardiol; 2019 Mar; 73(3):228-232. PubMed ID: 30579806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.
    Park SJ; Kang SJ; Ahn JM; Chang M; Yun SC; Roh JH; Lee PH; Park HW; Yoon SH; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Han KH; Park SW
    J Am Coll Cardiol; 2016 Apr; 67(15):1772-1783. PubMed ID: 27081016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.
    Hou J; Xing L; Jia H; Vergallo R; Soeda T; Minami Y; Hu S; Yang S; Zhang S; Lee H; Yu B; Jang IK
    Am J Cardiol; 2016 Mar; 117(5):800-6. PubMed ID: 26778524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.
    Thondapu V; Kurihara O; Yonetsu T; Russo M; Kim HO; Lee H; Soeda T; Minami Y; Jang IK
    Am J Cardiol; 2019 May; 123(10):1565-1571. PubMed ID: 30851941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.
    Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Terashima M; Michishita I
    Am Heart J; 2012 Feb; 163(2):191-9.e1. PubMed ID: 22305836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial change and its determinants of residual plaque characteristics under sirolimus-eluting stent: a coronary angioscopic study.
    Kanai T; Hiro T; Takayama T; Watanabe Y; Fukamachi D; Kitano D; Kawano T; Hirayama A
    J Cardiol; 2012 Oct; 60(4):270-6. PubMed ID: 22819742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHAR trial with intravascular ultrasound and coronary angioscopy.
    Takayama T; Hiro T; Ueda Y; Saito S; Kodama K; Komatsu S; Hirayama A
    Heart Vessels; 2015 Mar; 30(2):169-76. PubMed ID: 24463843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Daida H; Takayama T; Hiro T; Yamagishi M; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Diabetol; 2012 Jul; 11():87. PubMed ID: 22831708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy).
    Kini AS; Baber U; Kovacic JC; Limaye A; Ali ZA; Sweeny J; Maehara A; Mehran R; Dangas G; Mintz GS; Fuster V; Narula J; Sharma SK; Moreno PR
    J Am Coll Cardiol; 2013 Jul; 62(1):21-9. PubMed ID: 23644090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound.
    Hirayama A; Saito S; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Nanto S; Takazawa K; Kodama K
    Circ J; 2011; 75(6):1448-54. PubMed ID: 21502706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: Assessment with serial coronary CT angiography.
    Auscher S; Heinsen L; Nieman K; Vinther KH; Løgstrup B; Møller JE; Broersen A; Kitslaar P; Lambrechtsen J; Egstrup K
    Atherosclerosis; 2015 Aug; 241(2):579-87. PubMed ID: 26115069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of baseline plaque components on plaque progression in nonintervened coronary segments in patients with angina pectoris on rosuvastatin 10 mg/day.
    Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2010 Nov; 106(9):1241-7. PubMed ID: 21029819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques.
    Qian C; Wei B; Ding J; Wu H; Cai X; Li B; Wang Y
    Am J Cardiol; 2015 Nov; 116(10):1521-6. PubMed ID: 26385518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
    Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
    J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial.
    Egede R; Jensen LO; Hansen HS; Hansen KN; Junker A; Thayssen P
    EuroIntervention; 2013 Feb; 8(10):1182-9. PubMed ID: 22987572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.